Elicio Therapeutics Activates Phase 1 Study of ELI-002 7P
Boston, Aug. 10, 2026 Elicio Therapeutics, Inc. announced the activation of an investigator-initiated Phase 1 clinical study evaluating its...
medical technology
Advertisement
Telomir Pharmaceuticals Publishes Telomir-Zn Cancer Data
Miami, August 10, 2026 Telomir Pharmaceuticals, Inc. announced the peer-reviewed publication of preclinical data showing that Telomir-Zn suppressed tumor...
Revvity Launches SuperFlex Prenatal Screening System
Waltham, Mass., August 10, 2026 Revvity, Inc. announced the launch of its SuperFlex™ prenatal screening system, a compact, CE-IVDR...
Moderna Begins Phase 1 Trial for Ebola mRNA Vaccine
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
Integer to Be Acquired by KKR in $5.7 Billion Deal
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
Advertisements
Galaxy Therapeutics Secures CE Mark for SEAL System
Milpitas, California, August 4, 2026 Galaxy Therapeutics has announced that its SEAL™ Embolization System has received CE Mark certification...
Intelligent Bio Solutions Advances FDA 510(k) Drug Screening Study
New York, August 3, 2026 Intelligent Bio Solutions Inc. (INBS) announced the completion of an Interference Study for its...
Leads Biolabs Gains China IND for Opamtistomig in mCRC
NANJING, China, August 3, 2026 Leads Biolabs announced that the Center for Drug Evaluation (CDE) of China’s National Medical...
Avenda Health Expands Unfold AI Across Prostate Cancer Care
CULVER CITY, Calif., July 28, 2026 Avenda Health announced that its FDA-cleared Unfold AI platform is now being used...
Smith+Nephew Sets New Standard in Sports Medicine AI
LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...
Advertisement
